Skip to main content
. 2021 May-Jun;37(3):897–902. doi: 10.12669/pjms.37.3.3312

Table I.

Baseline Characteristics of patients with Pelvic organ prolapse.

Pelvic organ prolapse (Stage 1 and 2) (n=72) Pelvic organ prolapse (Stage 3 and 4) (n=63) p-value
Age (years) (Mean±SD) 55.67 (9.82) 62.108 (10.54) <0.001*
Parity (median (IQR)) 4 (3-5) 4(3-5) 0.813
BMI (kg/m2) (median(IQR)) 26.5 (23.6-32) 25. 4(23.6-31.6) 0.637
Duration of symptoms (months) (median (IQR)) 10 (8-12) 12 (8-12) 0.338
Use of anticholinergics
No 49 (80.3%) 53 (71.6%) 0.241
Yes 12 (19.7%) 18 (28.4%)
OAB symptoms more than 12 months n(%)
No 31 (50.8%) 41 (55.4%)
Yes 30 (49.2%) 33 (44.6%) 0.595
HTN 0.552
No 27 (44.3%) 29 (39.2%)
Yes 34 (55.7%) 45 (60.8%)
DM
No 41 (67.2%) 43 (58.1%)
Yes 20(32.8%) 31 (41.9%) 0.278
Hypothyroid
No 58 (95.1%) 67 (90.5%) 0.511
Yes 3 (4.9%) 7 (9.5%)
Aa point (cm) (median (IQR)) 1 6 (3-7) <0.001*
Ba- point(cm) (median (IQR)) 1 6 (4-7) <0.001*
Ap point (cm) (median (IQR)) 0 (0-1) 4 (2-7) <0.01*
Bp point (cm) (median (IQR)) 0 (0-1) 4 (2-7) <0.001*
C point (cm) (median (IQR)) 1 (0-1) 5 (2-7) <0.001*
D point (cm) (median (IQR)) 8 6 (4-8) <0.001*

Data are mean±standard deviation, median ( interquartile range (IQR)) or number (%), BMI: Body Mass Index, HTN: Hypertension, DM: Diabetes mellitus,

*

significant at p-value <0.05 by using Independent t-test / Mann whitney U test